|
Group 1: NMO
|
16
|
13/3
|
55.02 +/- 9.80
|
| | | |
(40-63)
|
|
Group 2: MS
|
85
|
60/25
|
39.43 +/-9.40
|
|
(18-76)
|
|
- Relapsing-remitting MS
|
72
| | |
|
- Secondary progressive MS
|
3
| | |
|
- Primary progressive MS
|
10
| | |
|
Group 3: idiopathic ON
|
24
|
17/7
|
35.01 +/- 11.39
|
|
(14-62)
|
|
-Isolated episode
|
15
| | |
|
-Recurrent idiopathic ON
|
9
| | |
|
Group 4: idiopathic myelitis
|
21
|
14/7
|
46.30 +/- 14.27
|
|
(21-68)
|
|
-Isolated episode:
|
18
| | |
|
> 3 vertebral segments
|
9
| | |
|
≤ 3 vertebral segments
|
9
| | |
|
-Recurrent idiopathic myelitis
|
3
| | |
|
Group 5: other neurological disorders
|
13
|
7/6
|
50.45 +/- 6.11
|
|
(42-59)
|
|
-Myelitis associated with lupus
|
2
| | |
|
-ON associated with Sjögren syndrome
|
1
| | |
|
-Multifocal motor neuropathy
|
2
| | |
|
-CIDP
|
1
| | |
|
-Spinal infarction
|
2
| | |
|
-Ischemic optic neuropathy
|
5
| | |
|
Group 6: healthy controls
|
8
|
5/3
|
34.45 +/- 8.31
|
| | | |
(27-50)
|
